Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
批准号:
10666280
负责人:
Fabian ERNESTO Saenz
金额:
$12.94万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-01 至 2028-03-31
关键词:
AllelesAnnual ReportsAntigenic DiversityAntigensAppearanceAreaBackBiological AssayBorder CrossingsCharacteristicsCitiesClinicalColombiaColombianCountryDiseaseDisease OutbreaksEcuadorEpidemiologyExposure toFalciparum MalariaGeneticGenetic MarkersGenetic RecombinationGenomeGenomicsGenotypeGoalsGrowthImmune responseImmunityImmunoglobulin GIn VitroIndividualInfectionKnowledgeMaintenanceMalariaMeasurementModelingNatural ImmunityOutcomeParasitesPeriodicalsPlasmaPlasmodium falciparumPlayPopulationPrevalenceProvincePublic HealthRecombinantsRecording of previous eventsReportingRoleSamplingSerologySerology testSeveritiesSeverity of illnessSignal TransductionSouth AmericanStressValidationacquired immunitybiosignaturecross reactivitydisease transmissionexperimental studygenome sequencingimprovedin vitro Assayinnovationmalaria transmissionnew outbreaknovelpreventresponseserological markertransmission processwhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Malaria continues to severely impact public health in countries around the world. Some countries like Ecuador
made impressive progress in the first 10-15 years of this century. Nevertheless, recent years have seen
stagnation and malaria cases are increasing again. While most cases of Plasmodium falciparum in Northwest
Ecuador appear to originate in the Pacific coast of Colombia, asymptomatic reservoirs of this parasite are
common and may be important in maintaining transmission within Ecuador. One of the main problems for
malaria elimination is the presence of asymptomatic reservoirs. To better understand the malaria transmission
dynamics in this pre-eliminating region, we will characterize the genetics of the parasites circulating in
northwest Ecuador (symptomatic and asymptomatic), identify serological biosignatures of infection and define
the relationships between the clinical outcome of the infection, parasite genetics and serological markers.
Lastly, we will validate the role of acquired immunity in disease severity, clonal persistence, and outbreak
emergence through innovative in vitro assays. This project will inform local control decisions in Ecuador, and,
most importantly, provide a model for understanding disease persistence in other pre-elimination settings
around the world.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金